openPR Logo
Press release

Artificial Lung: A Leading Driver Behind The Rising Prevalence Of Respiratory Diseases Fuels Artificial Lung Market Market Expansion in 2025

08-01-2025 12:10 PM CET | Health & Medicine

Press release from: The Business Research Company

Artificial Lung

Artificial Lung

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Artificial Lung Industry Market Size Be by 2025?
The market size of the artificial lung has been exhibiting rapid growth recently. It is projected to increase from $2.31 billion in 2024 to $2.59 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 12.2%. Factors that have contributed to this growth in the previous years include increased awareness among healthcare professionals, enhanced market penetration, greater use in home care settings, a surge in medical tourism, and advancements in healthcare infrastructure.

What's the Long-Term Growth Forecast for the Artificial Lung Market Size Through 2029?
In the forthcoming years, the artificial lung market is projected to witness swift expansion, escalating to a worth of $4.06 billion in 2029 with a compound annual growth rate (CAGR) of 11.9%. The market's growth during the forecast period can be linked to the increasing instances of respiratory diseases, enhancements in healthcare amenities, growing adoption of minimally invasive techniques, improvements in patient lifestyle, and a higher occurrence of chronic obstructive pulmonary diseases. Key market trends for the forecast period encompass the incorporation of wireless technology, integration of artificial intelligence (AI), progress in the realm of genomics and medical technology, along with the advent of smaller, easily transportable artificial lungs.

View the full report here:
https://www.thebusinessresearchcompany.com/report/artificial-lung-global-market-report

What Are the Key Growth Drivers Fueling the Artificial Lung Market Expansion?
Rise in respiratory illnesses is anticipated to boost the artificial lung market's expansion in the future. The surge in respiratory conditions can be attributed to increased air pollution, climate change, and lifestyle modifications, all of which put considerable strain on public health. The function of artificial lungs is to oxygenate the blood and eliminate carbon dioxide, thus aiding or taking over the role of deficient lungs in patients with respiratory issues. For example, in June 2024, the Australian Institute of Health and Welfare, a health and welfare organization based in Australia, projected that roughly 8.5 million individuals, or 34% of Australia's population, had chronic respiratory ailments. This estimate includes roughly 2.8 million people, or 11% of the population, who suffer from asthma, and 638,000 people, or 2.5% of the population, who have chronic obstructive pulmonary disease (COPD). Consequently, the growing incidence of respiratory diseases is promoting the growth of the artificial lung market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16591&type=smp

What Are the Key Trends Driving Artificial Lung Market Growth?
Leading corporations in the artificial lung sector are concentrating on the invention of unique solutions like remote control and observation of the device for competitive advantage. This method facilitates medical personnel to keep a check on the crucial parameters of patients and modify ventilation settings without the necessity of being personally near the patient, thus decreasing infection risks and improving the safety of patients during therapy. For instance, Teltonika Telemedic, an American electronics production firm, made considerable headway in the creation of its artificial lung ventilator called TELTOMED in August 2022. The company successfully acquired an exclusive patent for the safeguarded remote data transition and controller of the ventilator. This innovation amplifies the security and trustworthiness of patient data communication, a fundamental characteristic of contemporary medical equipment.

How Is the Artificial Lung Market Segmented?
The artificial lung market covered in this report is segmented -

1) By Product Type: Single Roller Pump Heart Lung Machines, Double Roller Pump Heart Lungs Machines, Bubble Artificial Lung, Membrane Artificial Lung
2) By Application: Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Other Applications
3) By End-Users: Hospital, Emergency Center, Other End-users

Subsegments:
1) By Single Roller Pump Heart Lung Machines: Portable Single Roller Pump Heart Lung Machines, Stationary Single Roller Pump Heart Lung Machines
2) By Double Roller Pump Heart Lung Machines: Portable Double Roller Pump Heart Lung Machines, Stationary Double Roller Pump Heart Lung Machines
3) By Bubble Artificial Lung: Disposable Bubble Artificial Lung, Reusable Bubble Artificial Lung
4) By Membrane Artificial Lung: Oxygenator Membrane Artificial Lung, Carbon Dioxide Removal Membrane Artificial Lung

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16591&type=smp

Which Companies Are Leading the Charge in Artificial Lung Market Innovation?
Major companies operating in the artificial lung market are Terumo Corporation, Getinge AB, Abiomed Inc., MicroPort Scientific Corp., Charles Stark Laboratory Inc., TransMedics Group Inc., Braile Biomédica Ltd., Xenios AG, MC3 Cardiopulmonary Inc., Lung Biotechnology PBC, Breethe Inc., Levitronix LLC, Medos Medizintechnik AG, ALung Technologies Inc., McGowan Institute for Regenerative Medicine, Hemovent GmbH, Novalung GmbH, Haemair Ltd., MedArray Inc., Vivonics Inc., Extracorporeal Life Support (ECLS) Lab

Which Regions Are Leading the Global Artificial Lung Market in Revenue?
North America was the largest region in the artificial lung market in 2024. The regions covered in the artificial lung market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16591

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Artificial Lung: A Leading Driver Behind The Rising Prevalence Of Respiratory Diseases Fuels Artificial Lung Market Market Expansion in 2025 here

News-ID: 4129607 • Views:

More Releases from The Business Research Company

Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by 2029
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025? Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billion by 2029
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. What is the Projected Market Size of the Rheology Modifiers Industry? There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analysis Report
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025? In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growth at 7.1% CAGR Forecast
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. What is the Projected Market Size of the Pharmaceutical Intermediates Industry? There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound

All 5 Releases


More Releases for Lung

Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: Core Growth Enabler …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Lung Cancer Drugs Industry Market Size Be by 2025? The market for lung cancer medications has seen a swift expansion in previous years. The market size is projected to escalate from $47.94 billion in 2024 to $54.13 billion in 2025, with a compound annual growth rate
Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: An Emerging Driver …
The Lending And Payments Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Lending And Payments Market? The lending and payments market has experienced strong growth in recent years. It is set to rise from $12,326.44 billion in 2024 to
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market? The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market? The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and
Lung Cancer Screening Market - Empowering Proactive Lung Health: The Future of C …
Newark, New Castle, USA: The "Lung Cancer Screening Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Lung Cancer Screening Market: https://www.growthplusreports.com/report/lung-cancer-screening-market/7787 This latest report researches the industry structure,
Artificial Lung Market May Set New Growth Story | Breethe, Lung Biotechnology, M …
A new research document is added in HTF MI database of 37 pages, titled as 'Artificial Lung - Medical Devices Pipeline Assessment, 2020' with detailed analysis, Competitive landscape, forecast and strategies. The study covers important players/vendors such as ALung Technologies Inc, Breethe, Inc., Case Western Reserve University, Lung Biotechnology PBC, MC3 Inc, McGowan Institute for Regenerative , Medicine, Miromatrix Medical Inc, The Charles Stark Draper Laboratory Inc, U.S. Ann Arbor